Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DYNPORT VACCINE COMPANY LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-07-20 to 2023-07-18
Current total value of award: $1213178
Description: EVALUATION OF CELL LINES PRODUCING A MONOCLONAL ANTIBODY, AND PRODUCTION AND CHARACTERIZATION OF A CGMP MASTER CELL BANK